employer glp-1 coverage news Designing fiscally viable of weight-loss drugs Poll: 1 in 8 Adults

consumers between 16 and 65 years of age, and found that Ozempic topped all health care brands considered in the study beating the companies CVS (Health), Warby Parker (a perennial health consumer favorite in other research), Pfizer (still associated with the COVID-19 vaccine) and Truvani (a brand of protein powder)

Why It Matters: The meteoric rise of GLP-1 weight-loss drugs is reshaping not only global healthcare but also retail pharmacy economics

With semaglutide no longer in shortage, Novo says compounded versions are not justified

100% Financing and Telehealth Available

GLP 1 medications do far more than support weight loss

PlexusDx offers personalized semaglutide therapy tailored to your unique biology